Company Coverage
China Resources Land (1109 HK): Takeaways From Channel Checks And 1H26 Results Preview
BUY (Maintained)
Current price:
Target price:
Upside:
Previous TP :
HK$34.62
HK$39.60
+14.4%
HK$42.40
Analyst
Analyst
Highlights
- We expect notably lower profit contribution from the DP segment. We forecast around a 30% yoy decline in DP revenue and over 5ppt yoy contraction in DP gross margin in 1H26, partly due to a higher inventory provision.
- CR Mixc malls continue to outperform. Recurring income grew 7.6% yoy in 1H26, with rental income up 12.6% yoy, with high teens tenant sales growth and high single-digit SSSG. Gains from the Chengdu Mixc REIT listing should help keep core net profit and DPS stable.
- We cut our 2026/27/28 core net profit forecasts by 12.7%/12.7%/14.8% respectively, reflecting more conservative DP revenue and gross margin assumptions. Reiterate BUY with a lower target price of HK$39.60.
Analysis
- We had a channel check on CR Land on 16 July. Our key takeaways are:
- Expect notably lower profit contribution from DP segment. Despite the industry downturn, CR Land’s development properties (DP) segment has been reporting resilient top-line growth during 2023-25. However, for 2026, we expect DP revenue to decline from the high base in 2025. For 1H26, we forecast around a 30% yoy reduction in DP revenue, and over 5ppt yoy reduction in DP gross profit margin from 15.6% in 1H25, partly due to higher inventory provision of over Rmb2b (vs Rmb1.55b in 1H25) and continued downward pressure on booking margin.
- CR Mixc malls continue to strongly outperform the market. For 1H26, we expect CR Land’s malls to see high-teens growth in total tenant sales and a high single-digit growth in same-store sales growth (SSSG). The luxury segment continued to outperform the CR Mixc portfolio. According to CR Land, recurring income grew at 7.6% yoy in 1H26, of which rental income grew at 12.6% yoy. We expect recurring income growth in the interim results to be close to this level, with recurring business margins broadly stable, which in our view implies a marked increase in the share of investment properties (IP) in both revenue and profit.
Highlights
- We expect notably lower profit contribution from the DP segment. We forecast around a 30% yoy decline in DP revenue and over 5ppt yoy contraction in DP gross margin in 1H26, partly due to a higher inventory provision.
- CR Mixc malls continue to outperform. Recurring income grew 7.6% yoy in 1H26, with rental income up 12.6% yoy, with high teens tenant sales growth and high single-digit SSSG. Gains from the Chengdu Mixc REIT listing should help keep core net profit and DPS stable.
- We cut our 2026/27/28 core net profit forecasts by 12.7%/12.7%/14.8% respectively, reflecting more conservative DP revenue and gross margin assumptions. Reiterate BUY with a lower target price of HK$39.60.
Analysis
- We had a channel check on CR Land on 16 July. Our key takeaways are:
- Expect notably lower profit contribution from DP segment. Despite the industry downturn, CR Land’s development properties (DP) segment has been reporting resilient top-line growth during 2023-25. However, for 2026, we expect DP revenue to decline from the high base in 2025. For 1H26, we forecast around a 30% yoy reduction in DP revenue, and over 5ppt yoy reduction in DP gross profit margin from 15.6% in 1H25, partly due to higher inventory provision of over Rmb2b (vs Rmb1.55b in 1H25) and continued downward pressure on booking margin.
- CR Mixc malls continue to strongly outperform the market. For 1H26, we expect CR Land’s malls to see high-teens growth in total tenant sales and a high single-digit growth in same-store sales growth (SSSG). The luxury segment continued to outperform the CR Mixc portfolio. According to CR Land, recurring income grew at 7.6% yoy in 1H26, of which rental income grew at 12.6% yoy. We expect recurring income growth in the interim results to be close to this level, with recurring business margins broadly stable, which in our view implies a marked increase in the share of investment properties (IP) in both revenue and profit.
BUY (Maintained)
Current price:
Target price:
Upside:
Previous TP :
HK$34.62
HK$39.60
+14.4%
HK$42.40
Analyst
Analyst
IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at the following link: https://research-api.uobkayhian.com/assets/disclaimer/df64a6ea-7980-447c-ae9e-fd19b93257dc, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.
Related articles
21 Jul 2026
Yuexiu Property (123 HK): Takeaways From Profit Warning And 1H26 Results Preview
20 Jul 2026
Longfor Group (960 HK): Takeaways From Channel Checks And 1H26 Results Preview
16 Jul 2026
China Overseas Land & Investment (688 HK): Takeaways From Channel Checks And 1H26 Results Preview
Our latest research
24 Jul 2026
TA: Xiaomi (1810 HK) / Sino Biopharmaceutical (1177 HK)
24 Jul 2026
Sino Biopharmaceutical (1177 HK): Innovation Continues To Fuel Growth
24 Jul 2026